Parkinson's disease (PD) is the second most predominant neurodegenerative disease
worldwide. It is recognized clinically by severe complications in motor function caused by …

Background Cell-based strategies focusing on replacement or protection of dopaminergic
neurons have been considered as a potential approach to treat Parkinson's disease (PD) for …

Chronic liver diseases have become a significant health issue worldwide and urgently
require the development of novel therapeutic approaches, in addition to liver transplantation …

Cell-based therapies are an emerging biopharmaceutical paradigm under investigation for
the treatment of a range of neurological disorders. Accumulating evidence is demonstrating …

Abstract Background The pathogenesis of Parkinson's disease (PD) has not been fully
elucidated, and there are no effective disease-modifying drugs for the treatment of PD …

Background: Lack of participation of black and minority ethnic communities (BAME) in
registered clinical trials is a concern as data emerging from these studies are used to licence …

Although striatal delivery of three critical genes for dopamine synthesis by viruses is a
potential clinical approach for treating Parkinson's disease (PD), the approach makes it …

Skin ageing is predominantly caused by either intrinsic or extrinsic factors, leading to
undesirable skin features. Advancements in both molecular and cellular fields have created …

Applying stem cell therapy in intractable diseases: a narrative review of decades of progress
and challenges - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Background Cognitive impairment is common in Parkinson's disease (PD) and has a
substantial impact on quality of life. Despite numerous trials targeting various PD features …